Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
11/09/201717:05GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
11/09/201709:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid BioservicesNASDAQ:CDMOPAvid Bioservices Inc
07/09/201709:10GlobeNewswire Inc.Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combinati...NASDAQ:CDMOPAvid Bioservices Inc
06/09/201717:05GlobeNewswire Inc.Peregrine to Report Financial Results for First Quarter of Fiscal Year 2018 After Market Close on September 11, 2017NASDAQ:CDMOPAvid Bioservices Inc
05/09/201717:05GlobeNewswire Inc.Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
16/08/201709:05GlobeNewswire Inc.Avid Bioservices to Exhibit at The Bioprocessing Summit 2017NASDAQ:CDMOPAvid Bioservices Inc
11/08/201709:30GlobeNewswire Inc.Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its OperationsNASDAQ:CDMOPAvid Bioservices Inc
31/07/201709:30GlobeNewswire Inc.Peregrine Provides Strategic UpdateNASDAQ:CDMOPAvid Bioservices Inc
14/07/201717:14GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
13/07/201719:08GlobeNewswire Inc.Peregrine Pharmaceuticals Issues Statement Regarding Ronin Trading and SW Investment Management’s Letter to StockholdersNASDAQ:CDMOPAvid Bioservices Inc
07/07/201717:05GlobeNewswire Inc.Peregrine to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2017 After Market Close on July 14, 2017NASDAQ:CDMOPAvid Bioservices Inc
07/07/201711:25GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Reverse Stock SplitNASDAQ:CDMOPAvid Bioservices Inc
06/06/201717:05GlobeNewswire Inc.Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
05/06/201709:05GlobeNewswire Inc.Peregrine Pharmaceuticals Presents Preliminary Correlative Analysis of PD-L1 Expression from SUNRISE Trial at ASCO 2017NASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP